BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements
05 sept. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at...
BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor
31 juil. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., July 31, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
Sigma(R) Life Science Appoints Impress Public Relations as Agency of Record
03 nov. 2009 10h00 HE
|
Impress Public Relations
PHOENIX, AZ--(Marketwire - November 3, 2009) - Impress
Public Relations, Inc. today announced that it has been appointed as
public relations agency of record by Sigma Life
Science, part of the...